Chrysophanol inhibits nalp3 inflammasome activation and ameliorates cerebral ischemia/reperfusion in mice

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Zhang, Nan ^a   Zhang, Xiangjian ^a,b,c   Liu, Xiaoxia ^a   Wang, Hong ^a   Xue, Jing ^a   Yu, Jingying ^a   Kang, Ning ^a   Wang, Xiaolu ^b  

^a Medical University   (China)

^b Hebei Collaborative Innovation Center for Cardio cerebrovascular Disease   (China)

^c Hebei Key Laboratory for Neurology   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHRYSOPHANIC ACID; CRYOPYRIN; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; MESSENGER RNA; ANTHRAQUINONE DERIVATIVE; CARRIER PROTEIN; CIAS1 PROTEIN, MOUSE; INFLAMMASOME; PLANT EXTRACT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CORTEX; BRAIN EDEMA; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN WATER; CELLULAR DISTRIBUTION; CHROMATIN; CORPUS STRIATUM; CYTOPLASM; HEMISPHERE; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NEUROPROTECTION; NEUTROPHIL; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; BRAIN; CONFOCAL MICROSCOPY; DISEASE MODEL; DRUG EFFECTS; INFLAMMATION; METABOLISM; PATHOLOGY; PERMEABILITY; PHYSIOLOGY; REPERFUSION INJURY; STROKE;

ANIMALS; ANTHRAQUINONES; BLOOD-BRAIN BARRIER; BRAIN; BRAIN ISCHEMIA; CARRIER PROTEINS; CEREBRAL INFARCTION; DISEASE MODELS, ANIMAL; INFLAMMASOMES; INFLAMMATION; MALE; MICE; MICROSCOPY, CONFOCAL; PERMEABILITY; PLANT EXTRACTS; REPERFUSION INJURY; STROKE;

EID: 84901044619     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/370530     Document Type: Article

References (55)

1. Donnan G. A., Fisher M., Macleod M., Davis S. M., Stroke. The Lancet 2008 371 9624 1612 1623 2-s2.0-43049135853 10.1016/S0140-6736(08)60694-7
2. Qiao H., Zhang X., Zhu C., Dong L., Wang L., Zhang X., Xing Y., Wang C., Ji Y., Cao X., Luteolin downregulates TLR4, TLR5, NF- B and p-p38MAPK expression, upregulates the p-ERK expression, and protects rat brains against focal ischemia. Brain Research 2012 1448 71 81 2-s2.0-84858701903 10.1016/j.brainres.2012.02.003
3. Li H., Yin J., Li L., Deng J., Feng C., Zuo Z., Isofluranepostconditioning reduces ischemia-induced nuclear factor- B activation and interleukin 1 β production to provide neuroprotection in rats and mice. Neurobiology of Disease 2013 54 216 224
4. Salskov-Iversen M. L., Johansen C., Kragballe K., Iversen L., Caspase-5 expression is upregulated in lesional psoriatic skin. The Journal of Investigative Dermatology 2011 131 3 670 676 2-s2.0-79951509223 10.1038/jid.2010.370
5. Zhou R., Tardivel A., Thorens B., Choi I., Tschopp J., Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nature Immunology 2010 11 2 136 140 2-s2.0-75649096002 10.1038/ni.1831
6. Mariathasan S., Hewton K., Monack D. M., Vucic D., French D. M., Lee W. P., Roose-Girma M., Erickson S., Dixit V. M., Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 2004 430 6996 213 218 2-s2.0-3142654767 10.1038/nature02664
7. Zhang C., Boini K. M., Xia M., Abais J. M., Li X., Liu Q., Li P. L., Activation of Nod-like receptor protein 3 inflammasomes turns on podocyte injury and glomerular sclerosis in hyperhomocysteinemia. Hypertension 2012 60 1 154 162
8. Martinon F., Signaling by ROS drives inflammasome activation. European Journal of Immunology 2010 40 3 616 619 2-s2.0-77749304032 10.1002/eji.200940168
9. Martinon F., Pétrilli V., Mayor A., Tardivel A., Tschopp J., Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006 440 7081 237 241 2-s2.0-32944468985 10.1038/nature04516
10. Schorn C., Frey B., Lauber K., Janko C., Strysio M., Keppeler H., Gaipl U. S., Voll R. E., Springer E., Munoz L. E., Schett G., Herrmann M., Sodium overload and water influx activate the NALP3 inflammasome. The Journal of Biological Chemistry 2011 286 1 35 41 2-s2.0-78650926948 10.1074/jbc.M110.139048
11. Sutterwala F. S., Ogura Y., Zamboni D. S., Roy C. R., Flavell R. A., NALP3: a key player in caspase-1 activation. Journal of Endotoxin Research 2006 12 4 251 256 2-s2.0-33749047649 10.1179/096805106X118771
12. Stunden H. J., Latz E., PKR stirs up inflammasomes. Cell Research 2013 23 2 168 170
13. Wen C., Yang X., Yan Z., Zhao M., Yue X., Cheng X., Zheng Z., Guan K., Dou J., Xu T., Zhang Y., Song T., Wei C., Zhong H., Nalp3 inflammasome is activated and required for vascular smooth muscle cell calcification. International Journal of Cardiology 2013 168 3 2242 2247 10.1016/j.ijcard.2013. 01.211
14. Blomgran R., Brodin V. P., Verma D., Bergström I., Söderkvist P., Sjöwall C., Eriksson P., Lerm M., Stendahl O., Särndahl E., Common genetic variations in the NALP3 inflammasome are associated with delayed apoptosis of human neutrophils. PLoS ONE 2012 7 3 2-s2.0-84857743749 10.1371/journal.pone.0031326 e31326
15. Shaftel S. S., Carlson T. J., Olschowka J. A., Kyrkanides S., Matousek S. B., O'Banion M. K., Chronic interleukin-1 β expression in mouse brain leads to leukocyte infiltration and neutrophil-independent blood-brain barrier permeability without overt neurodegeneration. The Journal of Neuroscience 2007 27 35 9301 9309 2-s2.0-34548434392 10.1523/JNEUROSCI.1418-07.2007
16. Jha S., Srivastava S. Y., Brickey W. J., Iocca H., Toews A., Morrison J. P., Chen V. S., Gris D., Matsushima G. K., Ting J. P.-Y., The inflammasome sensor, NLRP3, regulates CNS inflammation and demyelination via caspase-1 and interleukin-18. The Journal of Neuroscience 2010 30 47 15811 15820 2-s2.0-78649396261 10.1523/JNEUROSCI.4088-10.2010
17. Mariathasan S., Weiss D. S., Newton K., McBride J., O'Rourke K., Roose-Girma M., Lee W. P., Weinrauch Y., Monack D. M., Dixit V. M., Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 2006 440 7081 228 232 2-s2.0-32944470765 10.1038/nature04515
18. Willingham S. B., Bergstralh D. T., O'Connor W., Morrison A. C., Taxman D. J., Duncan J. A., Barnoy S., Venkatesan M. M., Flavell R. A., Deshmukh M., Hoffman H., Ting J. P.-Y., Microbial pathogen-induced necrotic cell death mediated by the inflammasome components CIAS1/cryopyrin/NLRP3 and ASC. Cell Host & Microbe 2007 2 3 147 159 2-s2.0-34548386663 10.1016/j.chom.2007.07.009
19. Kim S.-J., Kim M.-C., Lee B.-J., Park D.-H., Hong S.-H., Um J.-Y., Anti-inflammatory activity of chrysophanol through the suppression of NF- B/caspase-1 activation in vitro and in vivo. Molecules 2010 15 9 6436 6451 2-s2.0-77957296084 10.3390/molecules15096436
20. Longa E. Z., Weinstein P. R., Carlson S., Cummins R., Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989 20 1 84 91 2-s2.0-0024494427
21. Yang C., Zhang X., Fan H., Liu Y., Curcumin upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia. Brain Research 2009 1282 133 141 2-s2.0-67649670106 10.1016/j.brainres.2009.05. 009
22. Cheatwood J. L., Emerick A. J., Schwab M. E., Kartje G. L., Nogo-A expression after focal ischemic stroke in the adult rat. Stroke 2008 39 7 2091 2098 2-s2.0-47649116873 10.1161/STROKEAHA.107.507426
23. Hayakawa K., Mishima K., Nozako M., Hazekawa M., Mishima S., Fujioka M., Orito K., Egashira N., Iwasaki K., Fujiwara M., Delayed treatment with minocycline ameliorates neurologic impairment through activated microglia expressing a high-mobility group box1-inhibiting mechanism. Stroke 2008 39 3 951 958 2-s2.0-41249088005 10.1161/STROKEAHA.107.495820
24. Liu Y., Zhang X.-J., Yang C.-H., Fan H.-G., Oxymatrine protects rat brains against permanent focal ischemia and downregulates NF- B expression. Brain Research 2009 1268 174 180 2-s2.0-64149117795 10.1016/j.brainres.2009.02. 069
25. Simonyi A., Wang Q., Miller R. L., Yusof M., Shelat P. B., Sun A. Y., Sun G. Y., Polyphenols in cerebral ischemia: novel targets for neuroprotection. Molecular Neurobiology 2005 31 1-3 135 147 2-s2.0-20344382855 10.1385/MN:31:1-3:135
26. Hatashita S., Hoff J. T., Salamat S. M., Ischemic brain edema and the osmotic gradient between blood and brain. Journal of Cerebral Blood Flow and Metabolism 1988 8 4 552 559 2-s2.0-0023719493
27. Huang J., Li Y., Tang Y., Tang G., Yang G. Y., Wang Y., CXCR4 antagonist AMD3100 protects blood-brain barrier integrity and reduces inflammatory response after focal ischemia in mice. Stroke 2013 44 1 190 197
28. Gladstone D. J., Black S. E., Hakim A. M., Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions. Stroke 2002 33 8 2123 2136 2-s2.0-0036330007 10.1161/01.STR.0000025518.34157.51
29. Legos J. J., Tuma R. F., Barone F. C., Pharmacological interventions for stroke: failures and future. Expert Opinion on Investigational Drugs 2002 11 5 603 614 2-s2.0-0035999884 10.1517/13543784.11.5.603
30. Hacke W., Donnan G., Fieschi C., Kaste M., von Kummer R., Broderick J. P., Brott T., Frankel M., Grotta J. C., Haley E. C. Jr., Kwiatkowski T., Levine S. R., Lewandowski C., Lu M., Lyden P., Marler J. R., Patel S., Tilley B. C., Albers G., Bluhmki E., Wilhelm M., Hamilton S., Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. The Lancet 2004 363 9411 768 774
31. Rabuffetti M., Sciorati C., Tarozzo G., Clementi E., Manfredi A. A., Beltramo M., Inhibition of caspase-1-like activity by Ac-Tyr-Val-Ala-Asp- chloromethyl ketone induces long-lasting neuroprotection in cerebral ischemia through apoptosis reduction and decrease of proinflammatory cytokines. The Journal of Neuroscience 2000 20 12 4398 4404 2-s2.0-0034660250
32. Rothwell N. J., Luheshi G. N., Interleukin 1 in the brain: biology, pathology and therapeutic target. Trends in Neurosciences 2000 23 12 618 625 2-s2.0-0034534995 10.1016/S0166-2236(00)01661-1
33. Hedtjärn M., Leverin A.-L., Eriksson K., Blomgren K., Mallard C., Hagberg H., Interleukin-18 involvement in hypoxic-ischemic brain injury. The Journal of Neuroscience 2002 22 14 5910 5919 2-s2.0-0037101645
34. Danton G. H., Dietrich W. D., The search for neuroprotective strategies in stroke. American Journal of Neuroradiology 2004 25 2 181 194 2-s2.0-1242339543
35. Lucas S.-M., Rothwell N. J., Gibson R. M., The role of inflammation in CNS injury and disease. British Journal of Pharmacology 2006 147 1 S232 S240 2-s2.0-30444459031 10.1038/sj.bjp.0706400
36. Feng S. X., Li J. S., Qu L. B., Shi Y. M., Zhao D., Comparative pharmacokinetics of five rhubarb anthraquinones in normal and thrombotic focal cerebral ischemia-induced rats. Phytotherapy Research 2013 27 10 1489 1494
37. Huang Q., Lu G., Shen H.-M., Chung M. C. M., Choon N. O., Anti-cancer properties of anthraquinones from rhubarb. Medicinal Research Reviews 2007 27 5 609 630 2-s2.0-34548047015 10.1002/med.20094
38. Shoemaker M., Hamilton B., Dairkee S. H., Cohen I., Campbell M. J., In vitro anticancer activity of twelve Chinese medicinal herbs. Phytotherapy Research 2005 19 7 649 651 2-s2.0-25444513400 10.1002/ptr.1702
39. Arosio B., Gagliano N., Fusaro L. M. P., Parmeggiani L., Tagliabue J., Galetti P., De Castri D., Moscheni C., Annoni G., Aloe-emodin quinone pretreatment reduces acute liver injury induced by carbon tetrachloride. Pharmacology & Toxicology 2000 87 5 229 233 2-s2.0-0033678216
40. Fosse C., Le Texier L., Roy S., Delaforge M., Grégoire S., Neuwels M., Azerad R., Parameters and mechanistic studies on the oxadative ring cleavage of synthetic heterocyclic naphthoquinones by Streptomyces strains. Applied Microbiology and Biotechnology 2004 65 4 446 456 2-s2.0-4644362055 10.1007/s00253-004-1588-4
41. Rim H. K., Moon P. D., Choi I. H., Lee E. H., Kim H. M., Jeong H. J., SoSoSo or its active ingredient chrysophanol regulates production of inflammatory cytokines & adipokine in both macrophages & adipocytes. The Indian Journal of Medical Research 2013 137 1 142 150
42. Lee Y. S., Ju H. K., Kim Y. J., Lim T. G., Uddin M. R., Kim Y. B., Baek J. H., Kwon S. W., Lee K. W., Seo H. S., Park S. U., Yang T. J., Enhancement of anti-inflammatory activity of Aloe vera adventitious root extracts through the alteration of primary and secondary metabolites via salicylic acid elicitation. PloS ONE 2013 8 12 10.1371/journal.pone.0082479 e82479
43. Mishra S. K., Tiwari S., Shrivastava A., Srivastava S., Boudh G. K., Chourasia S. K., Chaturvedi U., Mir S. S., Saxena A. K., Bhatia G., Lakshmi V., Antidyslipidemic effect and antioxidant activity of anthraquinone derivatives from Rheum emodi rhizomes in dyslipidemic rats. Journal of Natural Medicines 2013 68 2 363 371 10.1007/s11418-013-0810-z
44. Mason J. L., Suzuki K., Chaplin D. D., Matsushima G. K., Interleukin-1 β promotes repair of the CNS. The Journal of Neuroscience 2001 21 18 7046 7052 2-s2.0-0035883161
45. Zhu P., Duan L., Chen J., Xiong A., Xu Q., Zhang H., Zheng F., Tan Z., Gong F., Fang M., Gene silencing of NALP3 protects against liver ischemia-reperfusion injury in mice. Human Gene Therapy 2011 22 7 853 864 2-s2.0-79960371987 10.1089/hum.2010.145
46. Shigeoka A. A., Mueller J. L., Kambo A., Mathison J. C., King A. J., Hall W. F., Da Silva Correia J., Ulevitch R. J., Hoffman H. M., McKay D. B., An inflammasome-independent role for epithelial-expressed Nlrp3 in renal ischemia-reperfusion injury. Journal of Immunology 2010 185 10 6277 6285 2-s2.0-78650659200 10.4049/jimmunol.1002330
47. Gris D., Ye Z., Iocca H. A., Wen H., Craven R. R., Gris P., Huang M., Schneider M., Miller S. D., Ting J. P.-Y., NLRP3 plays a critical role in the development of experimental autoimmune encephalomyelitis by mediating Th1 and Th17 responses. Journal of Immunology 2010 185 2 974 981 2-s2.0-77955475968 10.4049/jimmunol.0904145
48. Abulafia D. P., de Rivero Vaccari J. P., Lozano J. D., Lotocki G., Keane R. W., Dietrich W. D., Inhibition of the inflammasome complex reduces the inflammatory response after thromboembolic stroke in mice. Journal of Cerebral Blood Flow and Metabolism 2009 29 3 534 544 2-s2.0-61349152312 10.1038/jcbfm.2008.143
49. Lindauer M., Wong J., Magun B., Ricin toxin activates the NALP3 inflammasome. Toxins 2010 2 6 1500 1514 2-s2.0-79952076264 10.3390/toxins2061500
50. Bostanci N., Emingil G., Saygan B., Turkoglu O., Atilla G., Curtis M. A., Belibasakis G. N., Expression and regulation of the NALP3 inflammasome complex in periodontal diseases. Clinical and Experimental Immunology 2009 157 3 415 422 2-s2.0-67651214207 10.1111/j.1365-2249.2009.03972.x
51. Zedler S., Faist E., The impact of endogenous triggers on trauma-associated inflammation. Current Opinion in Critical Care 2006 12 6 595 601 2-s2.0-33750537772 10.1097/MCC.0b013e3280106806
52. Pétrilli V., Papin S., Dostert C., Mayor A., Martinon F., Tschopp J., Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death and Differentiation 2007 14 9 1583 1589 2-s2.0-34548027736 10.1038/sj.cdd.4402195
53. Miao Z.-M., Zhao S.-H., Yan S.-L., Li C.-G., Wang Y.-G., Meng D.-M., Zhou L., Mi Q.-S., NALP3 inflammasome functional polymorphisms and gout susceptibility. Cell Cycle 2009 8 1 27 30 2-s2.0-60749136794
54. Ferrero-Miliani L., Nielsen O. H., Andersen P. S., Girardin S. E., Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1 β generation. Clinical and Experimental Immunology 2007 147 2 227 235 2-s2.0-33846257261 10.1111/j.1365-2249.2006.03261.x
55. Martinon F., Detection of immune danger signals by NALP3. Journal of Leukocyte Biology 2008 83 3 507 511 2-s2.0-43349086139 10.1189/jlb.0607362